Risk of pneumonia-related hospitalization after initiating angiotensin-converting enzyme inhibitors compared with angiotensin Ⅱ receptor blockers: a retrospective cohort study using LIFE Study data.
Risk of pneumonia-related hospitalization after initiating angiotensin-converting enzyme inhibitors compared with angiotensin Ⅱ receptor blockers: a retrospective cohort study using LIFE Study data.